GLP-1 users on online forums describe reduced cravings and less interest in cannabis
Rosenstock J, Wysham C, Frias JP, Kaneko S, Lee CJ, Lando LF, et al
Thus, Medicare and Medicaid exclude obesity GLP-1s , covering these agents only when used for on-label diabetes or cardiovascular indications
One key difference is that the doses used for weight loss are higher, which allows it to work on the brains receptors
I called these the big buck tubes ($300.00 pr)
The results indicated that the mRNA and protein expression levels of GLP-1R were significantly increased in ASM cells transfected with pcDNA3.1-Glp-1R, and significantly decreased in those transfected with GLP-1R siRNA (data not shown)